Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · QuidelOrtho (QDEL)

QuidelOrtho posts $10.78 loss per share on $701 million impairment

Mixed Impact 4 of 5 earnings Written later

QuidelOrtho reported third-quarter 2025 results with revenue of $700 million, down 4% from $727 million a year earlier, mainly due to lower COVID-19 and Donor Screening revenue. A $701 million non-cash goodwill impairment charge drove a GAAP net loss of $733 million, while adjusted diluted EPS was $0.80 versus $0.85 and adjusted EBITDA rose to $177 million from $171 million. The company narrowed its full-year 2025 revenue and adjusted EBITDA guidance ranges and updated adjusted EPS guidance to $2.00 to $2.15 to reflect its debt refinancing.

Key points

  • Q3 2025 total revenue was $700 million, down 4% as reported; non-respiratory revenue rose 5% as reported
  • GAAP diluted loss per share was $10.78 versus a $0.30 loss a year earlier, including a $701 million goodwill impairment charge
  • Adjusted EBITDA was $177 million, a 25% margin, compared with $171 million and 23% a year earlier
  • Full-year 2025 guidance: revenue $2.68 to $2.74 billion, adjusted EBITDA $585 to $605 million, adjusted diluted EPS $2.00 to $2.15

The filing

CompanyQuidelOrtho (QDEL)
Form8-K, current report
Filed with the SECNov 5, 2025, 4:08 PM ET
Accession number0001906324-25-000158

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:07 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.